Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Hello Bag Holders

<< Previous

Bullboard Posts

Next >>

Post by Duster340on May 28, 2021 1:12pm

280 Views

Post# 33286910

Hello Bag Holders

another month has come and gone, only 4 more months of dead money to go hang in there lol. . i have built up a nice nest egg ready to deploy here in september prior to the run-up in stock price. in the mean time i sugest to avoid investing in ate and invest in stocks that are on the move such as in the energy sector and also i have put some cash into some of the beat up pot stocks that operate in the usa. i think they will do very good moving forward. catalyst coming next year for them.
glta

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program